A Comprehensive Review of TORCH Syndrome: Characterization and Prevention Strategies
DOI:
https://doi.org/10.12775/QS.2024.21.53987Keywords
TORCH syndrome, perinatal infections, Toxoplasmosis, Rubella, CMV infection, Herpes Simplex Virus infectionAbstract
Abstract:
Introduction: TORCH syndrome refers to a group of symptoms caused by congenital infections with teratogenic pathogens, including Toxoplasma gondii, Varicella, Treponema pallidum, Parvovirus B19, Rubella, Cytomegalovirus (CMV), and Herpes simplex virus (HSV). It can also encompass infections like HIV, Zika virus (ZIKV), hepatitis B, and SARS-CoV-2. These pathogens can pass through the placenta, overcoming various placental barriers. Infections during pregnancy can result in severe consequences for both the fetus and the mother. Common symptoms in newborns include low birth weight, rashes, hepatosplenomegaly, cardiac anomalies, jaundice, chorioretinitis, and microcephaly, with 2% to 3% of congenital anomalies attributed to perinatal infections. The incidence of these infections varies globally.
Purpose of the work: This study aims to review and characterize TORCH syndrome and the prevention of TORCH infections.
Materials and methods: A comprehensive analysis of research papers available on PubMed, Google Scholar, Web of Science, Embase and Scopus was undertaken using the searchterms encompassing the following keywords: TORCH syndrome / infections during pregnancy / perinatal infections / Toxoplasmosis / Rubella / CMV infection / Herpes Simplex Virus infection / Parvovirus B19 / Treponema pallidum / vaccinations before and during pregnancy / maternal nutrition.
Results: TORCH syndrome is a significant issue causing congenital diseases, premature births, and intrauterine deaths, impacting babies throughout their lives. Most complications can be prevented with proper prophylaxis and early treatment. Increasing awareness and providing education for women from preconception through the early postnatal period is essential. Addressing TORCH syndrome remains a major medical challenge, but improving management offers hope for better outcomes.
References
Belanger B.G., Lui F.: Embryology, Teratology TORCH. https://www.ncbi.nlm.nih.gov/books/NBK545148/ (cited 24.07.2024).
Jaan A., Rajnik M.: TORCH Complex. https://www.ncbi.nlm.nih.gov/books/NBK560528/ (cited 24.07.2024).
Muldoon K.M., Fowler K.B., Pesch M.H., Schleiss M.R.: SARS-CoV-2: Is it the newest spark in the TORCH? Journal of clinical virology, 2020, 127, 104372.
Arora N., Sadovsky Y., Dermody T.S., Coyne C.B.: Microbial Vertical Transmission during Human Pregnancy. Cell Host Microbe, 2017, 21(5), 561-567.
Chan M.Y., Smith M.A.: Infections in Pregnancy. Comprehensive Toxicology, 2018, 232–249.
Zaga-Clavellina V., Diaz L., Olmos-Ortiz A., Godínez-Rubí M., Rojas-Mayorquín A.E., Ortuño-Sahagún D.: Central role of the placenta during viral infection: Immuno-competences and miRNA defensive responses. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021, 1867(10)
Kota A.S., Shabbir N.: Congenital Toxoplasmosis. https://pubmed.ncbi.nlm.nih.gov/31424812/ (cited 24.07.2024).
Toksoplazmoza. https://www.gov.pl/web/wsse-warszawa/epid-toksoplazmoza (cited 24.07.2024).
Czarkowski M. P., Staszewska-Jakubik E., Wielgosz U.: CHOROBY ZAKAŹNE I ZATRUCIA W POLSCE W 2020 ROKU. Narodowy Instytut Zdrowia Publicznego, Warszawa, 2021.
Megli C.J., Coyne C.B.: Infections at the maternal-fetal interface: an overview of pathogenesis and defence. Nature Reviews Microbiology, 2022, 20(2), 67-82.
Tesini B.L.: Toxoplasmosis in Newborns (Congenital Toxoplasmosis). https://www.msdmanuals.com/home/children-s-health-issues/infections-in-newborns/toxoplasmosis-in-newborns (cited 24.07.2024).
Wallon M., Kodjikian L., Binquet C., Garweg J., Fleury J., Quantin C., Peyron F.: Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics, 2004, 113(6), 1567-1572.
Talarek E.: Toksoplazmoza (zakażenie Toxoplasma gondii): przyczyny, objawy i leczenie. https://www.mp.pl/pacjent/choroby-zakazne/choroby/zarazenia-pasozytnicze/159099,toksoplazmoza (cited 24.07.2024).
Kota A.S., Shabbir N.: Congenital Toxoplasmosis. https://www.ncbi.nlm.nih.gov/books/NBK545228/ (cited 24.07.2024).
Bhavsar S., Mangat C.: Congenital Varicella Syndrome. https://www.ncbi.nlm.nih.gov/books/NBK568794/ (cited 24.07.2024).
Bhavsar S., Mangat C.: Congenital Varicella Syndrome. https://www.ncbi.nlm.nih.gov/books/NBK568794/ (cited 24.07.2024).
Duszczyk E., Dubiel B.: Ospa wietrzna. https://www.mp.pl/interna/chapter/B16.II.18.1.6. (cited 24.07.2024).
Hussain S.A., Vaidya R.: Congenital Syphilis. https://www.ncbi.nlm.nih.gov/books/NBK537087/ (cited 24.07.2024).
Congenital Syphilis. https://www.sciencedirect.com/topics/medicine-and-dentistry/congenital-syphilis (cited 24.07.2024).
Arnold S.R., Ford-Jones E.L.: Congenital syphilis: A guide to diagnosis and management. Paediatrics & child health, 2000, 5(8), 463-469.
Cvetnic W.G.: USMLE Step 2 CK Lecture Notes 2021 [w:] The Newborn. Kaplan Medical, New York, 2020, 18.
Singhal P., Patel P., Marfatia Y.S.: A case of congenital syphilis with Hutchinson's triad. Indian journal of sexually transmitted diseases and AIDS, 2011, 32(1), 34-6.
Hutchinson's Teeth. https://www.sciencedirect.com/topics/medicine-and-dentistry/hutchinsons-teeth (cited 24.07.2024).
Kiła. https://www.mp.pl/interna/chapter/B16.II.18.3.4.1.1.1. (cited 24.07.2024).
Giorgio E., De Oronzo M.A., Iozza I., Di Natale A., Cianci S., Garofalo G., Giacobbe A.M., Politi S.: Parvovirus B19 during pregnancy: a review. Journal of prenatal mededicine, 2010, 4(4), 63-66.
Bacz A.: Zakażenie parwowirusem B19 w ciąży. https://www.mp.pl/pacjent/ciaza/przebiegciazy/63108,zakazenie-parwowirusem-b19-w-ciazy (cited 24.07.2024).
Voordouw B., Rockx B., Jaenisch T., Fraaij P., Mayaud P., Vossen A., Koopmans M.: Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays. Clinical Microbiology Reviews, 2019, 33(1), e00130-18.
Freitas D.A., Souza-Santos R., Carvalho L.M.A., Barros W.B., Neves L.M., Brasil P.: Congenital Zika syndrome: A systematic review. PLoS ONE, 2020, 15(12), e0242367.
Congenital Zika syndrome. https://www.marchofdimes.org/complications/congenital-zika-syndrome.aspx (cited 25.07.2024).
Rymer W., Wroczyńska A., Nahorski W.L.: Wirus Zika – nowe globalne zagrożenie? https://www.mp.pl/pacjent/ciaza/aktualnosci/137758,wirus-zika-nowe-globalne-zagrozenie (cited 24.07.2024).
Gilroy S.A.: What is the prognosis of untreated HIV infection? https://www.medscape.com/answers/211316-6065/what-is-the-prognosis-of-untreated-hiv-infection (cited 25.07.2024).
Gray J.: HIV in the neonate. The Journal of hospital infection, 1997, 37(3), 181-198.
Abbas M., Bakhtyar A., Bazzi R.: Neonatal HIV. https://www.ncbi.nlm.nih.gov/books/NBK565879/ (cited 25.07.2024).
Dlaczego w Polsce jest najwięcej rejestrowanych zachorowań na różyczkę w Europie? https://szczepienia.pzh.gov.pl/faq/dlaczego-w-polsce-jest-najwiecej-rejestrowanych-zachorowan-na-rozyczke-w-europie/ (cited 25.07.2024).
Terracciano E., Amadori F., Pettinicchio V., Zaratti L., Franco E.: Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries. Jurnal of preventive medicine and hygiene, 2020, 61(1).
Szenborn L., Dubiel B.: Różyczka. https://www.mp.pl/interna/chapter/B16.II.18.1.5?fbclid=IwAR1WxfAKlnh7EFmZH1NfPR9EFGBxXN_tfVfTKcK7B3BC9yb_MKXpBn_E-7U (cited 25.07.2024).
Shukla S., Maraqa N.F.: Congenital Rubella. https://www.ncbi.nlm.nih.gov/books/NBK507879/ (cited 24.07.2024).
Drutz J.E.: Rubella. Pediatric in Review, 2010, 3(3), 129–130.
Akpan U.S., Pillarisetty L.S.: Congenital Cytomegalovirus Infection. https://www.ncbi.nlm.nih.gov/books/NBK541003/ (cited 25.07.2024).
Lisowska-Mikołajków D., Mikołajków A., Reczuch J., Królak-Olejnik B.: Zakażenie Wrodzone Wirusem Cytomegalii - Problem Wciąż Aktualny (na Podstawie Doświadczenia własnego Oraz Literatury). Developmental period medicine, 2018, 22(1), 49-57.
Kuchar E.: Zakażenia wrodzone z grupy TORCH – przewodnik postępowania w okresie pre- i postnatalnym. https://www.mp.pl/pediatria/wideo/219198,zakazenia-wrodzone-z-grupy-torch (cited 25.07.2024).
Bacz A.: Zakażenie wirusem cytomegalii w ciąży. https://www.mp.pl/pacjent/ciaza/przebiegciazy/63118,zakazenie-wirusem-cytomegalii-w-ciazy (cited 25.07.2024).
Fernandes N.D., Arya K., Ward R.: Congenital Herpes Simplex. https://www.ncbi.nlm.nih.gov/books/NBK507897/ (cited 25.07.2024)
Fernandes N.D., Arya K., Ward R.: Congenital Herpes Simplex. https://www.ncbi.nlm.nih.gov/books/NBK507897/ (cited 25.07.2024)
Straface G., Selmin A., Zanardo V., De Santis M., Ercoli A., Scambia G.: Herpes simplex virus infection in pregnancy. Infectious diseases in obstetrics and gynecology, 2012, 2012, 385697.
Bacz A.: Zakażenie narządów płciowych wirusem opryszczki u kobiet w ciąży. https://www.mp.pl/pacjent/ciaza/przebiegciazy/63122,zakazenie-narzadow-plciowych-wirusem-opryszczki-u-kobiet-w-ciazy (cited 25.07.2024).
Zaborowski P., Sawiec P.: Zakażenie wirusem opryszczki zwykłej. https://www.mp.pl/interna/chapter/B16.II.18.1.8. (cited 25.07.2024).
Mate A., Reyes-Goya C., Santana-Garrido Á., Sobrevia L., Vázquez C.M.: Impact of maternal nutrition in viral infections during pregnancy. Biochim Biophys Acta Mol Basis Dis, 2021, 1867(11).
Olejniczak D., Krakowiak K.: Ocena potrzeby edukacji zdrowotnej kobiet w ciąży w zakresie stylu życia i karmienia piersią. Nowa Pediatria, 2013, 3, 97-105.
Duszczyk E., Augustynowicz E.: Czy można szczepić kobiety w ciąży? https://szczepienia.pzh.gov.pl/wszystko-o-szczepieniach/jakie-szczepeinia-zaleca-sie-kobietom-w-ciazy/ (cited 25.07.2024).
Europejska Agencja Leków potwierdza bezpieczeństwo szczepień przeciw COVID-19 kobiet w ciąży. https://szczepienia.pzh.gov.pl/europejska-agencja-lekow-potwierdza-bezpieczenstwo-szczepien-przeciw-covid-19-kobiet-w-ciazy/ (cited 25.07.2024).
Vaccines During Pregnancy FAQs https://www.cdc.gov/vaccinesafety/concerns/vaccines-during-pregnancy.html#:~:text=CDC%20recommends%20that%20 pregnant%20 women,vaccine)%20and%20the%20Tdap%20vaccine (cited 25.07.2024).
Vaccine Safety for Moms-To-Be. https://www.cdc.gov/vaccines-pregnancy/vaccine-safety/?CDC_AAref_Val=https://www.cdc.gov/vaccines/pregnancy/vacc-safety.html (cited 25.07.2024).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Agata Konopka, Zuzanna Szczepaniak, Natalia Wdowiak, Karina Lissak, Małgorzata Komarów, Martyna Choinka, Dominika Karasińska, Jakub Kalisiak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 119
Number of citations: 0